Table 2.

Baseline data of included studies.

Author	Year	HIV status	Type of non-TB controls	Technology (MIG)	Antigen (MIG)	Sensitivity (%)	Specificity (%)	AUC	TP	FP	FN	TN
Manngo PM[11]	2019	9 (8.65%)	Other respiratory diseases	Multiplex immunoassay	Unstimulated	70	57	0.73	25	30	10	39
La Manna MP[12]	2018	None	Other respiratory diseases	Multiplex immunoassay	Stimulated	94.44	90	0.8944	25	2	2	18
Jacobs R[13]	2016	14 (25.5%)	Other respiratory diseases	Multiplex immunoassay	Unstimulated	68	88	0.81	15	4	7	29
Kim S[14]	2015	None	Healthy controls	RT-PCR	Stimulated	85.71	86.21	-	24	4	4	25
Chung W[15]	2015	None	Other respiratory diseases	ELISA	Unstimulated	81.1	88.5	0.89	163	6	38	46
Lee K[16]	2015	None	Healthy controls	ELISA	Unstimulated	89.3	89.1	0.935	147	28	18	228
Chung WY[17]	2014	None	Other respiratory diseases	ELISA	Stimulated	88.6	87.9	0.941	140	7	18	51
Wang X[18]	2012	None	Healthy controls	Microbead-based assay	Stimulated	85.4	80.8	0.896	152	30	26	126

AUC = area under curve, ELISA = enzyme-linked immunosorbent assay, FN = false negative, FP = false positive, HIV = human immunodeficiency virus, RT-PCR = reverse transcription-polymerase chain reaction, TB = tuberculosis, TN = true negative, TP = true positive.